Mehta Naaman, Bojko Areta, Lee Sarah S, Kulkarni Amita, Lekshmi Devika, Boyd Leslie, Robison Katina
New York University Grossman School of Medicine, Department of Obstetrics and Gynecology, United States.
Tufts University Department of Obstetrics and Gynecology, United States.
Gynecol Oncol Rep. 2025 May 28;59:101773. doi: 10.1016/j.gore.2025.101773. eCollection 2025 Jun.
The primary study objective was to determine the proportion of oncology physicians treating gynecologic oncology patients screening for sexual health concerns among patients with gynecologic malignancies. The secondary objective was to describe these physicians' perspectives on their role in evaluating sexual health concerns and barriers to managing sexual health in a gynecologic oncology office, by training level and gender.
This was a cross-sectional, quantitative, 23-item survey based on a previously validated questionnaire. It was administered across the United States to physicians (attendings and fellows) treating gynecologic oncology patients using the Society of Gynecologic Oncology database.
There was a 10.2 % response rate with 166/1621 physicians completing the survey. Thirty-four (23.1 %) were fellow trainees and 113 (77.0 %) were attendings. Most participants were gynecologic oncologists (155/166, 93.4 %), with radiation oncologists (1/166, 0.6 %), and other physicians (10/166, 6.0 %) also responding. The majority (137/166, 82.0 %) identified as female providers and (29/166, 17.4 %) identified as male. Just over half (99/166, 59.6 %) of providers routinely asked about sexual health concerns of their patients. Attendings more often discussed sexual health with patients when compared to fellows when controlling for academic setting and gender (OR 2.8, 95 % CI 1.6-4.1, p < 0.01). Most providers (117/166, 70.5 %) felt they needed to improve their knowledge on sexual function.
Of the limited surveyed, almost all feel sexual health should be discussed with their patients. Only about 59% routinely ask about sex health concerns. Future studies should focus on effective ways to incorporate sexual health screenings into gynecologic oncology clinics.
主要研究目的是确定治疗妇科肿瘤患者的肿瘤内科医生对妇科恶性肿瘤患者进行性健康问题筛查的比例。次要目的是按培训水平和性别描述这些医生对其在评估性健康问题中的作用以及在妇科肿瘤科室管理性健康的障碍的看法。
这是一项基于先前验证过的问卷的横断面定量调查,共23个项目。通过妇科肿瘤学会数据库,在美国对治疗妇科肿瘤患者的医生(主治医生和研究员)进行调查。
回复率为10.2%,166/1621名医生完成了调查。34名(23.1%)是实习研究员,113名(77.0%)是主治医生。大多数参与者是妇科肿瘤学家(155/166,93.4%),还有放射肿瘤学家(1/166,0.6%)和其他医生(10/166,6.0%)回复了调查。大多数(137/166,82.0%)被认定为女性医疗人员,(29/166,17.4%)被认定为男性。略超过一半(99/166,59.6%)的医疗人员会常规询问患者的性健康问题。在控制学术背景和性别后,与实习研究员相比,主治医生更常与患者讨论性健康问题(比值比2.8,95%置信区间1.6 - 4.1,p < 0.01)。大多数医疗人员(117/166,70.5%)觉得他们需要提高性功能方面的知识。
在有限的调查对象中,几乎所有人都认为应该与患者讨论性健康问题。只有约59%的人会常规询问性健康问题。未来的研究应聚焦于将性健康筛查纳入妇科肿瘤诊所的有效方法。